ResearcherUniversity of RegensburgActive in the last 2 years
Christina Hackl
Matched on OpenAlex author ID A5109099569. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research. Last author DOI 10.1038/s41598-025-87054-z↗
- The Effects of Analgesics on the Migration of Pancreatic Cancer Cells. First author DOI 10.21873/invivo.12740↗
- 3D In Vivo Models for Translational Research on Pancreatic Cancer: The Chorioallantoic Membrane (CAM) Model. Co-author DOI 10.3390/cancers14153733↗
- Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models. Co-author DOI 10.18632/oncotarget.15524↗
- STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases. Co-author DOI 10.1593/neo.12878↗
- Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer. Co-author PMID 22753713↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Benedikt J. Wagner · 2 shared papers, 2022–2025 · strength 0.35
- Paper Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer… DOI 10.1038/s41598-025-87054-z↗
- Paper 3D In Vivo Models for Translational Research on Pancreatic Cancer: The Chorioallantoic Membrane (CAM) Model. DOI 10.3390/cancers14153733↗
- Silke Haerteis · 2 shared papers, 2022–2025 · strength 0.35
- Paper Patient-derived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer… DOI 10.1038/s41598-025-87054-z↗
- Paper 3D In Vivo Models for Translational Research on Pancreatic Cancer: The Chorioallantoic Membrane (CAM) Model. DOI 10.3390/cancers14153733↗
- Katharina Maria Schmidt · 2 shared papers, 2017–2022 · strength 0.22
- Anika Bundscherer · 1 shared paper, 2022 · strength 0.20
- Bernhard Martin Graf · 1 shared paper, 2022 · strength 0.20
- Manuela Malsy · 1 shared paper, 2022 · strength 0.20
- Bettina Rau · 1 shared paper, 2025 · strength 0.20
- Eric Pion · 1 shared paper, 2022 · strength 0.15
- Sven Arke Lang · 3 shared papers, 2012–2017 · strength 0.13
- Paper Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models. DOI 10.18632/oncotarget.15524↗
- Paper Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer. PMID 22753713↗
- Paper STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases. DOI 10.1593/neo.12878↗
- Christoph W. Michalski · 1 shared paper, 2017 · strength 0.07
- Bo Kong · 1 shared paper, 2017 · strength 0.07
- Oliver Stoeltzing · 2 shared papers, 2012 · strength 0.06
- Christian Moser · 2 shared papers, 2012 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.